Diabetic Neuropathy

As per available reports about 556 journals, 165 Conferences, 32 workshops are presently dedicated exclusively to Diabetic Neuropathy and about 318,004 articles are being published on the current trends in Diabetic Neuropathy. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Diabetic Neuropathy are being carried out. As reported in Anders A. F. Sima, et al article, Diabetic neuropathy (DPN) is a dynamic condition affecting both type 1 and type 2 diabetic subjects. It can be divided into an early and reversible metabolic phase of nerve dysfunction. This is caused by hyperglycemia-induced activation of the polyol-pathway, redox imbalances as well as by insulin/C-peptide deficiencies resulting in impaired neural Na+/K+-ATPase activity and impairment of endoneurial blood flow.

Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. These condition is thought to result from diabetic microvascular injury involving small blood vessels that supply nerves in addition to macrovascular conditions that can culminate in diabetic neuropathy.

Journal of Diabetes & Metabolism is a free medical journal that publishes discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc., The journal is using Editorial Manager System for peer review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Diabetes & Metabolism or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication.